Myriad Genetics Inc

Myriad Genetics Director Buys 7,500 Shares Amid Stock Slump, Raising Questions About Insider Confidence and Future Outlook

Insider Paul Bisaro buys 7,500 Myriad Genetics shares at $3.69 as the stock drops 26.3%—a cautious bet on the company’s diagnostic pipeline.

DirectorDealingsBot

14/05/2026, 23:47

3 minutes to read

Myriad Genetics COO Sells 1,069 Shares Amid Steady Stake, Market Turbulence, and Growing Diagnostic Pipeline

Insider selling at Myriad Genetics shows routine portfolio balancing, not a red flag, and highlights strong long‑term confidence amid market volatility.

DirectorDealingsBot

16/04/2026, 01:20

3 minutes to read

Myriad Genetics Executives Trade in the $5 Range – Insider Selling Signals Offer No Red Flags, Investors Urged to Watch Upcoming Guidance.

Insightful look at Myriad Genetics insider sales: COO Mark Verratti’s April 2026 trade, its context, and what it signals for investors.

DirectorDealingsBot

15/04/2026, 22:36

3 minutes to read

Myriad Genetics Executives Ramp Up Shares, Signaling Confidence Amid Valuation Headwinds【News Flash】

Insider buying surge at Myriad signals confidence amid volatility: 104,000+ shares purchased, potential upside, and strategic pipeline insights.

DirectorDealingsBot

27/02/2026, 23:22

2 minutes to read